Cartesian Therapeutics (RNAC) Total Liabilities (2015 - 2026)
Cartesian Therapeutics (RNAC) posted quarterly Total Liabilities of $436.5 million for Q1 2026, up 1.3% year-over-year from $430.9 million in Q1 2025, and up 3.28% quarter-over-quarter from $422.7 million in Q4 2025.
Cartesian Therapeutics (RNAC) Total Liabilities (2015 - 2026) Analysis & Trends
Cartesian Therapeutics (RNAC) has reported Total Liabilities for 12 consecutive years, with $436.5 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Total Liabilities rose 1.3% year-over-year to $436.5 million; the TTM figure through Mar 2026 stood at $436.5 million (up 1.3% YoY), while the FY2025 annual figure was $422.7 million, down 4.34% from the prior year.
- Total Liabilities improved to $436.5 million in Q1 2026 per RNAC's latest filing, from $422.7 million in the prior quarter.
- Across five years, Total Liabilities topped out at $454.6 million in Q3 2024 and bottomed at $45.7 million in Q3 2023.
- Historically, Total Liabilities has averaged $286.9 million across 5 years, with a median of $408.5 million in 2025.
- Annual changes were most pronounced in 2022 — Total Liabilities slumped 54.19% — and 2024, when it surged 894.56%.
- Cartesian Therapeutics' Total Liabilities stood at $72.1 million in 2022, then jumped by 517.11% to $444.7 million in 2023, then decreased by 0.64% to $441.8 million in 2024, then retreated by 4.34% to $422.7 million in 2025, then gained by 3.28% to $436.5 million in 2026.
- Business Quant data shows RNAC's Total Liabilities at $436.5 million in Q1 2026, $422.7 million in Q4 2025, and $408.5 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 7.18 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 10.02 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 1.62 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 1.72 Bn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 4.00 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 7.02 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 10.03 Bn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 4.20 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 1.35 Bn |
| 10 | Cartesian Therapeutics | 265.54 Mn | 265.54 Mn | - | 443.85 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 443.85 Mn |
| Mar 31, 2026 | 436.51 Mn |
| Dec 31, 2025 | 422.65 Mn |
| Sep 30, 2025 | 408.52 Mn |
| Jun 30, 2025 | 391.42 Mn |
| Mar 31, 2025 | 430.92 Mn |
| Dec 31, 2024 | 441.83 Mn |
| Sep 30, 2024 | 454.56 Mn |
| Jun 30, 2024 | 449.20 Mn |
| Mar 31, 2024 | 442.01 Mn |
| Dec 31, 2023 | 444.68 Mn |
| Sep 30, 2023 | 45.71 Mn |
| Jun 30, 2023 | 74.06 Mn |
| Mar 31, 2023 | 81.11 Mn |
| Dec 31, 2022 | 72.06 Mn |
| Sep 30, 2022 | 93.36 Mn |
| Jun 30, 2022 | 98.46 Mn |
| Mar 31, 2022 | 89.93 Mn |
| Dec 31, 2021 | 137.36 Mn |
| Sep 30, 2021 | 185.89 Mn |